The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Original Article
Complementary and Alternative Medicine Use among Heart Failure Patients in the Deep South
Abstract
Objective: Despite advancements in heart failure (HF) diagnostics and treatment, many palliative care patients with HF often seek complementary and alternative medicine (CAM) to improve quality of life and address unmet physical and emotional needs. This study aimed to explore the prevalence and patterns of CAM use among HF patients in a large academic medical ambulatory HF clinic in Alabama.Methods: This cross-sectional, descriptive study included HF patients from the University of Alabama at Birmingham HF clinic. Data collection involved CAM-related questions from the National Health Interview Survey, the Kansas City Cardiomyopathy Questionnaire, and sociodemographic variables. Descriptive statistics were computed for all study variables, and analyses were conducted using SPSS.
Results: Among 250 HF participants, 49 (19.6%) reported CAM use. The mean age of CAM users was 65 years (±14.76). Most CAM users were White (69%), male (63%), married or partnered (60%), had some college education (67%), and identified as Protestant (22%). The mean Kansas City Cardiomyopathy Questionnaire clinical summary score among CAM users was 54.48. Herbal products and dietary supplements were the most common CAM forms (57%). Of the CAM users, 53% discussed CAM with their healthcare providers, and 43% obtained CAM information from them. Regarding reasons for CAM use, 44.1% used it for pain relief, 29.4% for specific conditions, 20.6% for overall wellness, and 17.6% to complement conventional medicine; 15% cited multiple reasons. No significant sociodemographic predictors of CAM use were found.
Conclusion: CAM prevalence among HF patients in this cohort was relatively low compared with other populations. Herbal products and dietary supplements were the most common forms of CAM used. Further research is needed to assess the safety and efficacy of CAM, particularly herbal products and dietary supplements, in patients with HF.
Posted in: Cardiovascular Disease51
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Tobin DG, Lockwood MB, Kimmel PL, et al. Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nat Rev Nephrol 2022;18:113-128.
2. Kida K, Doi S, Suzuki N. Palliative care in patients with advanced heart failure. Heart Fail Clin 2020;16:243-254.
3. Hedrick R, Korouri S, Tadros E, et al. The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: a systematic review. Drugs Context 2020;9:2020-5-4.
4. Sbolli M, Fiuzat M, Cani D, et al. Depression and heart failure: the lonely comorbidity. Eur J Heart Fail 2020;22:2007-2017.
5. Nolan RP, Ross HJ, Farkouh ME, et al. Automated E-counseling for chronic heart failure: CHF-CePPORT trial. Circ Heart Fail 2021;14:e007073.
6. Chernoff RA, Messineo G, Kim S, et al. Psychosocial interventions for patients with heart failure and their impact on depression, anxiety, quality of life, morbidity, and mortality: a systematic review and meta-analysis. Psychosom Med 2022;84:560-580.
7. Heidenreich P, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145: e895–e1032.
8. Chow SL, Bozkurt B, Baker WL, et al. Complementary and alternative medicines in the management of heart failure: a Scientific Statement from the American Heart Association. Circulation 2023;147:e4-e30.
9. Muecke R, Paul M, Conrad C, et al. Complementary and alternative medicine in palliative care: a comparison of data from surveys among patients and professionals. Integr Cancer Ther 2016;15:10-16.
10. Wode K, Henriksson R, Sharp L, et al. Cancer patients’ use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med 2019;19:62.
11. Calcagni N, Gana K, Quintard B. A systematic review of complementary and alternative medicine in oncology: psychological and physical effects of manipulative and body-based practices. PloS One 2019;14:e0223564.
12. Kasprzycka K, Kurzawa M, Kucharz M, et al. Complementary and alternative medicine use in hospitalized cancer patients—study from Silesia, Poland. Int J Environ Res Public Health 2022;19:1600.
13. Armstrong M, Kupeli N, Flemming K, et al. Complementary therapy in palliative care: A synthesis of qualitative and quantitative systematic reviews. Palliat Med 2020;34:1332-1339.
14. Rashrash M, Schommer JC, Brown LM. Prevalence and predictors of herbal medicine use among adults in the United States. J Patient Exp 2017;4:108-113.
15. Salah AO, Salameh AD, Bitar MA, et al. Complementary and alternative medicine use in coronary heart disease patients: a cross-sectional study from Palestine. BMC Complement Med Ther 2020;20:231.
16. Shaito A, Thuan DTB, Phu HT, et al. Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety. Front Pharmacology 2020;11:422.
17. Grant SJ, Bin YS, Kiat H, et al. The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Public Health 2012;12:1-9.
18. Glynn P, Lloyd-Jones DM, Feinstein MJ, et al. Disparities in cardiovascular mortality related to heart failure in the United States. J Am Coll Cardiol 2019;73:2354-2355.
19. Loccoh EC, Joynt Maddox KE, Wang Y, et al. Rural-urban disparities in outcomes of myocardial infarction, heart failure, and stroke in the United States. J Am Coll Cardiol 2022; 79:267-279.
20. White-Williams C, Rossi LP, Bittner VA, et al. Addressing social determinants of health in the care of patients with heart failure: a Scientific Statement from the American Heart Association. Circulation 2020;141:e841-e863.
21. Bakitas MA, Dionne-Odom JN, Ejem DB, et al. Effect of an early palliative care telehealth intervention vs usual care on patients with heart failure: the ENABLE CHF-PC randomized clinical trial. JAMA Intern Med 2020;180:1203-1213.
22. US Public Health Service, National Center for Health Statistics. National Health Interview Survey. https://www.cdc.gov/nchs/nhis/documentation/index.html Accessed May 4, 2025.
23. Green CP, Porter CB, Bresnahan DR, et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245-1255.
24. Spertus JA, Jones PG, Sandhu AT, et al. Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC State-of-the-Art Review. Am Coll Cardiol 2020;76: 2379-2390.
25. Martin SS, Aday AW, Almarzooq ZI, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 2024;149:e347-e913.
26. Hassen G, Belete G, Carrera KG, et al. Clinical implications of herbal supplements in conventional medical practice: a US perspective. Cureus 2022;14:e26893.
27. Sile I, Teterovska R, Onzevs O, et al. Safety concerns related to the simultaneous use of prescription or over-the-counter medications and herbal medicinal products: survey results among Latvian citizens. Int J Environ Res Public Health 2023;20:6551.
28. Villaescusa L, Zaragoza C, Zaragoza F, et al. Herbal medicines for the treatment of cardiovascular diseases: benefits and risks–a narrative review. Int J Cardiol 2023;385:44-52.
29. Fjær EL, Landet ER, McNamara CL, et al. The use of complementary and alternative medicine (CAM) in Europe. BMC Complement Med Ther 2020;20:108.
30. Keene MR, Heslop IM, Sabesan SS, et al. Complementary and alternative medicine use in cancer: a systematic review. Complement Ther Clin Pract 2019;35:33-47.
31. Upchurch DM, Johnson PJ. Gender differences in prevalence, patterns, purposes, and perceived benefits of meditation practices in the United States. J Womens Health 2019;28: 135-142.
32. Lam CS, Arnott C, Beale AL, et al. Sex differences in heart failure. Eur Heart J 2019;40: 3859-3868c.
33. Chan E, Rooprai J, Rodger J, et al. Sex-based differences in referral of heart failure patients to outpatient clinics: a scoping review. ESC Heart Fail 2022;9:3702-3712.
34. Stöcker A, Mehnert-Theuerkauf A, Hinz A, Ernst J. Utilization of complementary and alternative medicine (CAM) by women with breast cancer or gynecological cancer. PloS One 2023;18:e0285718.
35. Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med 2010;7: 11-28.
36. Mackenzie ER, Taylor L, Bloom BS, et al. Ethnic minority use of complementary and alternative medicine (CAM): a national probability survey of CAM utilizers. Altern Ther Health Med 2003;9:50-56.
37. Agu JC, Hee-Jeon Y, Steel A, et al. A systematic review of traditional, complementary and alternative medicine use amongst ethnic minority populations: a focus upon prevalence, drivers, integrative use, health outcomes, referrals and use of information sources. J Immigr Minor Health 2019;21:1137-1156.
38. Foley H, Steel A, Cramer H, et al. Disclosure of complementary medicine use to medical providers: a systematic review and meta-analysis. Sci Rep 2019;9:1573.
39. Hamed S, Bradby H, Ahlberg BM, et al. Racism in healthcare: a scoping review. BMC Public Health 2022;22:988.
40. Falci L, Shi Z, Greenlee H. Multiple chronic conditions and use of complementary and alternative medicine among US adults: results from the 2012 National Health Interview Survey. Prev Chron Dis 2016;13:E61.
41. Johnson PJ, Jou J, Rockwood TH, et al. Perceived benefits of using complementary and alternative medicine by race/ethnicity among midlife and older adults in the United States. J Aging Health 2019;31:1376-1397.
42. Nayak A, Hicks AJ, Morris AA. Understanding the complexity of heart failure risk and treatment in Black patients. Circ Heart Fail 2020;13:e007264.
43. Batelaan K. ‘It’s not the science we distrust; it’s the scientists’: reframing the anti-vaccination movement within Black communities. Glob Public Health 2022;17:1099-1112.
44. Sullivan LS. Trust, risk, and race in American medicine. Hastings Center Rep 2020;50:18-26.
45. Paudyal V, Sun S, Hussain R, et al. Complementary and alternative medicines use in COVID19: a global perspective on practice, policy and research. Res Soc Admin Pharm 2022;18: 2524-2528.
46. Connell CL, Wang SC, Crook L, et al. Barriers to healthcare seeking and provision among African American adults in the rural Mississippi Delta region: community and provider perspectives. J Commun Health 2019;44:636-645.
47. Seifert G, Jeitler M, Stange R, et al. The relevance of complementary and integrative medicine in the COVID-19 pandemic: a qualitative review of the literature. Front Med 2020;7:587749.
